BBHC
HAE icon

Brown Brothers Harriman & Co’s Haemonetics HAE Stock Holding History

Brown Brothers Harriman & Co’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70
Closed -$5.61K – 1841
2025
Q4 		$5.61K Hold
70
– – ﹤0.01% 1481
2025
Q3 		$3.41K Buy
+70
New +$4.33K ﹤0.01% 1496
2022
Q4 		– Sell
-317
Closed -$23K – 1366
2022
Q3 		$23K Buy
+317
New +$22.8K ﹤0.01% 939
2019
Q2 		– Sell
-11
Closed -$1K – 1148
2019
Q1 		$1K Hold
11
– – ﹤0.01% 967
2018
Q4 		$1K Buy
+11
New +$1.16K ﹤0.01% 892

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brown Brothers Harriman & Co's HAE Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 70 shares — an estimated $5.61K sold.

Brown Brothers Harriman & Co first reported a position in HAE in Q4 2018 and held it in 5 quarters. The position peaked at $23K in Q3 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Brown Brothers Harriman & Co reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 70 Haemonetics shares in Q1 2026, an estimated $5.61K.
  • Brown Brothers Harriman & Co first reported a position in Haemonetics in Q4 2018 and held it in 5 quarters.
  • Brown Brothers Harriman & Co's Haemonetics position peaked at $23K in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.